• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Disclosed a Dahlia pinnata composition, Dahlia pinnata composition powders, a Dahlia pinnata cosmetic composition and a method for producing the same. A method for producing a Dahlia pinnata composition includes preparing Dahlia pinnata petals; adding and stirring ethanol into the Dahlia pinnata petals to extract Dahlia pinnata extract; filtering the Dahlia pinnata extract; and diluting the filtered Dahlia pinnata extract in a solvent to obtain a Dahlia pinnata composition having an antioxidant efficacy. The Dahlia pinnata composition is produced by the method for producing a Dahlia pinnata composition, and thus has an antioxidant efficacy. In addition, the cosmetic composition includes the Dahlia pinnata extract and thus has an antioxidant efficacy.
    公开号:EP3692979A1
    申请号:EP18902530.7
    申请日:2018-11-13
    公开日:2020-08-12
    发明作者:Rae Hyun Park；Han Na Jo；Keong A RYU；Dong Jin Jang；Sung Tae Kim
    申请人:Baram International Co Ltd；
    IPC主号:A61K8-00
    专利说明:
    [0001] The present disclosure relates to a Dahlia pinnata composition, Dahlia pinnata composition powders, a Dahlia pinnata cosmetic composition and a method for producing the same. More particularly, the present disclosure relates to a Dahlia pinnata composition, Dahlia pinnata composition powders, a Dahlia pinnata cosmetic composition, each having an extract of an effective ingredient from Dahlia pinnata petal having antioxidant effect, and a method for producing the same. Background Art
    [0002] In a process of energy production in a body, water, carbon dioxide and oxygen are generated. This oxygen is called free radical (reactive oxygen). This reactive oxygen performs an immune function and signal transduction function in the body. However, an excessively large amount of the reactive oxygen may cause aging and diseases. The excessive amount of the reactive oxygen may cause oxidative damage to various constituents (lipids, proteins, nucleic acids) in cells. In particular, a skin exposed to the outside may be continuously affected by the oxidative damage, thereby leading to the skin aging. Thus, such reactive oxygen is considered to be an important factor of the skin aging.
    [0003] A typical method to minimize the oxidative damage caused by the reactive oxygen and the resulting aging process is to intake physiologically active substances (e.g., vitamins, flavonoids, phenolic compounds, etc.) having antioxidant effect.
    [0004] In order to minimize the oxidative damage, not only such a physiologically active substance alone is digested, but also, a natural substance containing the same is digested. Thus, researches on extracting of natural antioxidant materials that maintain the antioxidant system in the body from natural materials are being actively carried out. Plants have a variety of secondary metabolites, which exhibit antioxidant activity and may be obtained from a variety of extracts. Because the secondary metabolites are natural materials, the secondary metabolites have an advantage that the secondary metabolites may be used relatively safely compared with a synthetic material.
    [0005] These natural antioxidant materials with antioxidant activity are applied throughout the industry and are ingested into the body through a variety of routes. In typical examples, the natural antioxidant materials are applied to foods and cosmetics, which are ingested into and applied onto the body, thereby reducing the oxidative damage and preventing the aging.
    [0006] Meanwhile, Dahlia pinnata is a perennial plant of dicotyledoneae Campanulales Asteraceae. Dahlia pinnata is a plant with features of tubers and herbs and is originated from Mexico. Dahlia pinnata is cultivated widely in various countries for ornamental use. Dahlia pinnata reproduces using sweet potato-like roots. The trunk of Dahlia pinnata is cylindrical, with many branches, no hairs, green and 1.5 to 2 m height. Leaves thereof are grown opposite to each other and split 1-2 times. The small leaf of Dahlia pinnata is ovate, with serrate on the edge, with a front face of the leaf being dark green, with a back face being white, and with the petiole having few wings.
    [0007] Roots of Dahlia pinnata have analgesic effect against dental pain caused by tooth decay. In addition, Dahlia pinnata petal is effective for diseases such as cardiovascular disease, dementia and cancer. Such a Dahlia pinnata petal-extract based composition may be used as a raw material for medicines for diseases such as cardiovascular diseases, dementia and cancer.
    [0008] A conventional document relating to an antioxidant active cosmetic composition using natural antioxidant materials may include Korean Patent Application No. 20020047048 titled "Cosmetic composition comprising extract of Rosa multiflora with antioxidative activity and preparation method of the extract", Korean Patent Application No. 20080107420 titled "Protective effects of Eucommia ulmoides on UVB-induced oxidative stress in human keratinocytes", and Korean Patent Application No. 20050021778 tilted "Cosmetic composition including Nelumbo nuciferaextract with antioxidant effect". However, all of the above documents fail to disclose an antioxidant activity composition including the above-described Dahlia pinnata extract as a major component. Disclosure Technical Goals
    [0009] A purpose of embodiments of the present disclosure is to provide a Dahlia pinnata composition, Dahlia pinnata composition powders, a Dahlia pinnata cosmetic composition, each having an extract of an effective ingredient from Dahlia pinnata petal having antioxidant effect, and a method for producing the same.
    [0010] Further, another purpose of embodiments of the present disclosure is to provide a Dahlia pinnata composition, Dahlia pinnata composition powders, a Dahlia pinnata cosmetic composition, each being added to foods or cosmetics, and imposing antioxidant effects to the foods or cosmetics and providing anti-aging effects, and a method for producing the same. Technical Solutions
    [0011] A cosmetic composition according to an embodiment will be described.
    [0012] The cosmetic composition including Dahlia pinnata extract may have an antioxidant efficacy.
    [0013] According to one aspect, the cosmetic composition may have a content of Dahlia pinnata extract ranging from 16 µg/ml to 20000 µg/ml. More preferably, the content of Dahlia pinnata extract may be in a range of from 500 µg/ml to 10000 µg/ml.
    [0014] A method for producing a Dahlia pinnata composition according to an embodiment will be described.
    [0015] The method for producing the Dahlia pinnata composition may include: preparing Dahlia pinnata petals; adding and stirring ethanol into the Dahlia pinnata petals to extract Dahlia pinnata extract; filtering the Dahlia pinnata extract; and diluting the filtered Dahlia pinnata extract in a solvent to obtain a Dahlia pinnata composition having an antioxidant efficacy.
    [0016] According to one aspect, in extracting the Dahlia pinnata extract, 5 to 20 ml of ethanol may be added per 1 g of the Dahlia pinnata petal to extract the Dahlia pinnata extract.
    [0017] According to one aspect, the Dahlia pinnata composition may have a phenolic compound content of 43.1 µg/100 mg to 56.5 µg/100 mg.
    [0018] According to one aspect, the Dahlia pinnata composition may have a content of the Dahlia pinnata extract ranging from 16 µg/ml to 20000 µg/ml.
    [0019] According to one aspect, the Dahlia pinnata composition may have a content of the Dahlia pinnata extract of 500 µg/ml to 10000 µg/ml.
    [0020] According to one aspect, the Dahlia pinnata composition may have an ability of an antioxidant component to remove 85% to 89% of DPPH (2,2-diphenyl-1-picrylhydrazyl) free radicals.
    [0021] According to one aspect, the Dahlia pinnata composition may have a content of the Dahlia pinnata extract ranging from 16 µg/ml to 400 µg/ml.
    [0022] According to one aspect, the Dahlia pinnata composition may have inhibition of 71.7% to 105.6% of superoxide dismutase activity.
    [0023] According to one aspect, filtering the Dahlia pinnata extract may include filtering the Dahlia pinnata extract with a syringe filter.
    [0024] A method for producing Dahlia pinnata composition powders according to an embodiment will be described.
    [0025] The method for producing Dahlia pinnata composition powders includes lyophilizing the Dahlia pinnata composition prepared by the above-described method; and converting the lyophilized Dahlia pinnata composition into powders form.
    [0026] The Dahlia pinnata composition and Dahlia pinnata composition powders having antioxidative effects may be prepared by the above-described preparation method.
    [0027] In addition, a cosmetic composition having antioxidant activity including the Dahlia pinnata composition prepared by the above-described preparation method may be prepared. Advantageous Effects
    [0028] The Dahlia pinnata composition prepared by extracting the effective ingredient from the Dahlia pinnata petal may be converted into a liquid or powders form, which may be easily added to food or cosmetics.
    [0029] In addition, the antioxidant effect may be exhibited from the food or cosmetic having the Dahlia pinnata composition, thereby to provide the anti-aging efficacy. Brief Description of Drawings
    [0030] FIG. 1 is a flowchart of the method for producing the Dahlia pinnata composition according to an embodiment.FIG. 2 is a flowchart of the method for producing the Dahlia pinnata composition powders according to an embodiment.FIG. 3 is a graph of the removal capability of free radical by the Dahlia pinnata composition according to an embodiment.FIG. 4 illustrates an inhibition rate of superoxide dismutase activity by the Dahlia pinnata composition according to an embodiment.Best Mode for Carrying Out the Invention
    [0031] Examples of various embodiments are illustrated and described further below with reference to the drawings. The same reference numbers in different figures denote the same or similar elements, and as such perform similar functionality. In other instances, well-known methods, procedures, components, and circuits have not been described in detail so as not to unnecessarily obscure aspects of the present disclosure.
    [0032] It will be understood that, although the terms "first", "second", "third", A, B, (a), (b) and so on may be used herein to describe various elements, these elements should not be limited by these terms. These terms are used to distinguish one element from another element. It will be understood that when an element is referred to as being "connected to", or "coupled to" or "accessed to" another element, it can be directly on, connected to, or coupled to, or acessed to the other element, or one or more intervening elements may be present.
    [0033] Components included in one embodiment may have the same name as a component having the same function in other embodiments. Unless otherwise stated, a description of one embodiment may be applied to other embodiments. A detailed description of overlapping portions between embodiments will be omitted.
    [0034] Prior to describing this embodiment, Dahlia pinnata extract means Dahlia pinnata petal component extracted by adding ethanol to Dahlia pinnata petal. Dahlia pinnata composition means a solvent including Dahlia pinnata extract. Further, a content (µg/ml) of Dahlia pinnata extract means the number of µg of Dahlia pinnata extract dissolved in 1 ml of Dahlia pinnata composition, that is, a solvent including Dahlia pinnata extract.
    [0035] Further, the cosmetic composition means a cosmetic material including Dahlia pinnata extract. The cosmetic material means a combination of additives or additives for producing cosmetics, the additives or additives being free of the Dahlia pinnata extract.
    [0036] The Dahlia pinnata petal includs a phenolic compound that inhibits oxidative damage by reactive oxygen and the progression of aging caused by the damage. Therefore, the Dahlia pinnata flower composition including the Dahlia pinnata petal extract has an antioxidant efficacy, which inhibits oxidative damage and progression of the aging. Such a Dahlia pinnata flower composition may have an antioxidant effect and thus may provide an antioxidant efficacy to the user when the composition is provided in the food or cosmetics form to the user. Further, Dahlia pinnata petals have different colors depending on the type. The composition including the Dahlia pinnata petal extracts may have different colors. This may easy to add colors in the food or cosmetics.
    [0037] The Dahlia pinnata petal extract may be added to cosmetics of various cosmetics such as cleansing cosmetics, basic cosmetics, color cosmetics, hair cosmetics, and functional cosmetics. Thus, the cosmetics may have antioxidant activity functions such as whitening and wrinkle improvement. Further, the cosmetic composition including the Dahlia pinnata extract has a color depending on the color of the petal. Thus, the cosmetic composition including the Dahlia pinnata extract may be used as a natural pigment for cosmetics such as makeup base, foundation, lipstick, eye shadow, and manicure.
    [0038] Hereinafter, a method for producing a Dahlia pinnata flower composition according to an embodiment will be described.
    [0039] FIG. 1 is a flowchart of the method for producing the Dahlia pinnata composition according to an embodiment.
    [0040] Referring to FIG. 1, the method for producing a Dahlia pinnata composition may include preparing Dahlia pinna petals (S10); extracting a Dahlia pinnata extract (S20); filtering the Dahlia pinnata extract (S30); and producing a Dahlia pinnata composition (S40).
    [0041] The step (S10) of preparing the Dahlia pinnata petals may include a step of preparing the Dahlia pinnata petal which has been cleaned of foreign matters and washed. For example, the foreign matter has been removed from the Dahlia pinnata petal which in turn has washed. Thus, 20 g of the petal may be prepared. However, this is only an example. The amount of Dahlia pinnata composition may be varied depending on the content of the Dahlia pinnata composition being produced.
    [0042] The step (S20) of extracting the Dahlia pinnata extract may include adding ethanol to the prepared Dahlia pinnata petals and stirring the mixture to extract the Dahlia pinnata extract including the antioxidant component. In this connection, this step may extract the Dahlia pinnata extract by adding 5 to 20 ml of ethanol per 1 g of the Dahlia pinnata petal. In a more preferred example, 10 ml of ethanol may be added per 1 g of the Dahlia pinnata petal to extract the Dahlia pinnata extract. For example, 200 ml of ethanol may be added to 20 g of Dahlia pinnata petal. Then, the Dahlia pinnata extract may be extracted by stirring the mixture at a room temperature for 5 hours at a speed of 30 rpm.
    [0043] The extraction of Dahlia pinnata flowers by distillation or squeezing may destroy effective components. Therefore, in the step of extracting the Dahlia pinnata extract, the ethanol may be added to extract the Dahlia pinnata petal extract. When the Dahlia pinnata petals are immersed in the ethanol, the effective component from the petals is completely dissolved into ethanol, and, thus, the solvent is vaporized away to obtain the extract only. In this way, the Dahlia pinnata extract can be extracted so that the effective ingredients included in the flower are not destroyed. In addition to the extraction method using the ethanol, the Dahlia pinnata flower extract can be extracted with volatile organic solvents such as petroleum ether, benzine, chloroform, etc. However, in the method using the volatile organic solvents, the toxicity may remain due to the residual organic solvents. Thus, the latter method is not suitable for producing the Dahlia pinnata compositions used in food or cosmetics.
    [0044] The step (S30) of filtering the Dahlia pinnata extract may filter the Dahlia pinnata extract with a filter and store the filtered extract at a temperature of 4°C. For example, the Dahlia pinnata extract may be filtered through a 25 mm syringe filter (HM) and stored in a refrigerator at 4°C.
    [0045] In this connection, a syringe filter is a disposable filter used to filter suspended matter in a liquid sample. The syringe filter may include a membrane filter that separates the mixture by separating and passing certain components therethrough. The syringe filter may be attached to the tip of the syringe. Then, a small amount of pressure is applied to the syringe, the extract may be filtered through the membrane filter.
    [0046] However, the syringe filter is just an example. Various filters that can filter the Dahlia pinnata extract may be employed.
    [0047] The step (S40) of producing the Dahlia pinnata composition may produce the Dahlia pinnata composition by diluting the filtered Dahlia pinnata extract in a solvent to adjust the content of the Dahlia pinnata extract. For example, ethanol may be used as a solvent in the step (S40) of producing the Dahlia pinnata composition. The Dahlia pinnata composition may be produced at a content of 100,000 µg/ml of the Dahlia pinnata extract relative to the solvent. Depending on the applications of the Dahlia pinnata composition, the extract may be diluted via the addition of the ethanol thereto. For example, the Dahlia pinnata composition may have a content 16 µg/ml to 20000 µg/ml of the Dahlia pinnata extract relative to the solvent. The Dahlia pinnata composition may be adjusted depending on the intended use thereof at a content ranging from 16 µg/ml to 20000 µg/ml of the Dahlia pinnata extract relative to the solvent.
    [0048] For example, the Dahlia pinnata composition may have a content of 500 µg/ml to 20000 µg/ml of the Dahlia pinnata extract relative to the solvent. In this case, the Dahlia pinnata composition may have a DPPH free radical removal capability of 85% to 89% by the antioxidant component. As another example, the Dahlia pinnata composition may have a content of 16 µg /ml to 400 µg/ml of the Dahlia pinnata extract relative to the solvent. In this case, the Dahlia pinnata composition may have an inhibition rate of 67.8% to 105.6% of the superoxide dismutase activity.
    [0049] As a more preferred example, the Dahlia pinnata composition may have a content of 500 µg/ml to 10000 µg/ml of Dahlia pinnata extract relative to the solvent. The Dahlia pinnata composition shows a high antioxidative activity when the content of Dahlia pinnata extract relative to the solvent is in a range of 500 µg/ml to 10000 µg/ml.
    [0050] Such a Dahlia pinnata composition may be added to the food in the form of a liquid and may be indigested. Such a Dahlia pinnata composition may be added to the cosmetic in the form of a liquid. In other words, the Dahlia pinnata composition may be composed of the diluted Dahlia pinnata extract in the ethanol. Then, the cosmetic or food composition may be produced by adding the Dahlia pinnata composition to the cosmetic or food products.
    [0051] In another example, the solvent may be the cosmetic material. In this case, a cosmetic composition including the Dahlia pinnata extract may be produced by adding the extract to the cosmetic material.
    [0052] The cosmetic composition may include the Dahlia pinnata extract at a content of 16 µg/ml to 20000 µg/ml. In a more preferred example, the cosmetic composition may include the Dahlia pinnata extract at a content of 500 µg/ml to 10000 µg/ml. The cosmetic composition including the Dahlia pinnata extract has antioxidant activity and has effects such as whitening, anti-aging, and wrinkle improvement.
    [0053] In this connection, the cosmetic composition may include a cosmetic material that includes various additives of different ingredients depending on the kinds of cosmetics such as cleansing cosmetics, basic cosmetics, color cosmetics, hair cosmetics, and functional cosmetics. The additives that constitute the cosmetic material may also use well-known additives for producing cosmetics. Therefore, detailed descriptions of the cosmetic additive may be omitted.
    [0054] In an embodiment, the solvent may be ethanol or cosmetic material, but the present disclosure is not limited thereto. The solvent may be embodied as a solvent added to the food.
    [0055] The Dahlia pinnata composition may also be produced in a powders form. The method for producing Dahlia pinnata composition powders will be described below with reference to FIG. 2.
    [0056] FIG. 2 is a flowchart of the method for producing the Dahlia pinnata composition powders according to the embodiment.
    [0057] Referring to FIG. 2, the method for producing powders of the Dahlia pinnata composition includes a step (S50) of lyophilizing the Dahlia pinnata composition produced by the method for producing the Dahlia pinnata composition as described above; and converting the lyophilized Dahlia pinnata composition into the powders form (S60).
    [0058] In the step (S50) of lyophilizing the Dahlia pinnata composition, the Dahlia pinnata composition is poured into a refrigerator using liquid nitrogen as a refrigerant and rapidly frozen at a temperature below -70°C. The Dahlia pinnata composition may be vacuum dried to reduce moisture content therein.
    [0059] In the step (S60) of converting the lyophilized Dahlia pinnata composition into the powders form, the lyophilized Dahlia pinnata composition may be added to a cryogenic freezing grinding mill and may be frozen and pulverized in the mill. In the cryogenic freezing mill, liquid nitrogen is injected thereto to attenuate the heat generated during the crushing process. The crushed Dahlia pinnata composition has the powders form. The powders-formed Dahlia pinnata extract may be added to food and cosmetics.
    [0060] The Dahlia pinnata composition in a liquid or powders form may include the phenolic compounds with an antioxidant efficacy. Further, it has been shown that the Dahlia pinnata composition has antioxidant activity to exhibit a high antioxidant effect. The Dahlia pinnata flowers have a variety of colors, so that they may be used as natural pigments in food and cosmetics, as well as the antioxidant and anti-aging agent.
    [0061] Hereinafter, the present disclosure will be described in more detail through Examples. It will be apparent to one of ordinary skill in the art that these Examples are only for the purpose of illustrating the present disclosure more specifically and that the scope of the present disclosure is not limited to these Examples. <Examples>
    [0062] 200 ml of ethanol was added to 20 g of Dahlia pinnata petal and stirred at a speed of 30 rpm for 5 hours at a room temperature to extract Dahlia pinnata extract. Then, Dahlia pinnata composition was prepared by filtering the extract through a 25 mm syringe filter and then controlling the content of the Dahlia pinnata extract via adding ethanol as a solvent thereto.
    [0063] Table 1 shows the contents of the Dahlia pinnata extract in the Dahlia pinnata composition according to each of Examples. [Table 1] Examples Dahlia pinnata extract content Example 1 250 µg/ml Example 2 500 µg/ml Example 3 1000 µg/ml Example 4 10000 µg/ml Example 5 20000 µg/ml Example 6 0.64 µg/ml Example 7 3.2 µg/ml Example 8 16 µg/ml Example 9 80 µg/ml Example 10 400 µg/ml Example 11 100000 µg/ml <Experimental Example 1>
    [0064] In Experimental Example 1, phenol content was measured by Folin Ciocalteau (F-C) Phenolic Content Quantification Assay. The Folin Ciocalteau (F-C) Phenolic content quantification analysis was performed by mixing 200 µl of 7% sodium carbonate (7% Na2CO3) in 10 µl of each of the Dahlia pinnata compositions of Example 1 to Example 11 to form mixtures, and by maintaining the mixtures at a room temperature for 3 minutes, and by dispensing the mixtures together with 10 µl of IN Folin Ciocalteau reagent (1N FC Reagent), and by maintaining the mixtures with the reagent at a room temperature for 30 minutes, and by measuring absorbances (750 nm) thereof using a microplate reader (Synergy™ HTX and Synergy™ 2 Multi-Mode Readers, BioTek). Gallic acid (Sigma Aldrich, USA) was used as a reference material.
    [0065] Table 2 is a table showing phenolic contents according to Experimental Example 1 for Examples 1 to 11.
    [0066] Referring to Table 2, the Dahlia pinnata composition of Example 1 to Example 11 will be described with respect to the phenol content as measured by the method of the Experimental Example 1. [Table 2] Examples Total phenolic content (µg/100 mg) Example 1 49.8 ± 6.7 Example 2 Example 3 Example 4 Example 5 Example 6 Example 7 Example 8 Example 9 Example 10 Example 11
    [0067] Example 1 to Example 11 have the total phenolic compound contents relative to the Dahlia pinnata extract as measured as from 43.1 µg/100 mg to 56.5 µg/100 mg although the total phenolic compound contents of Example 1 to Example 11 have small differences in accordance with the contents of Dahlia pinnata composition. The Dahlia pinnata compositions produced according to the Examples may include antioxidant properties because the compositions include the antioxidant phenolic compounds. The phenolic compounds have physiological activity such as anticancer activity in addition to antioxidant effect. Therefore, it could be known that the Dahlia pinnata composition may have effects such as antioxidant activity and anticancer activity when the composition is used in foods and cosmetics.
    [0068] Hereinafter, referring to FIG. 3, the results of measurement of radical removal capabilities by the compositions of Example 1 to Example 5 will be described via a DPPH method. <Comparative Example>
    [0069] L-Ascorbic acid (Sigma Aldrich, 50-81-7, USA) was added to ethanol so that the content of ascorbic acid included in ethanol was 50 µg/ml. Ascorbic acid is an organic compound with antioxidant properties. Ascorbic acid is one of the vitamins C and has a lactone structure. Ascorbic acid is an optically active compound widely used as an antioxidant for food additives. <Experimental Example 2>
    [0070] In Experimental Example 2, DPPH radical removal capability was measured for Example 1 to Example 5. To measure the DPPH radical removal capability, 100 µl of 0.2 mM DPPH solution dissolved in 99.5% methanol was added to 100 µl of each of the compositions of Example 1 to Example 5 and Comparative Example to form mixtures, and, then, in the mixtures, reactions occur at 37°C for 30 minutes. Then, the absorbances thereof were measured at 517 nm using a microplate reader (Synergy™ HTX and Synergy™ 2 Multi-Mode Readers, BioTek). Then, the DPPH radical removal capability was measured and thus the antioxidant capability was evaluated, and the measurement results in the graph of FIG. 3 were obtained.
    [0071] FIG. 3 is a graph of DPPH free radical removal capability measurements of the Dahlia pinnata compositions according to an embodiment.
    [0072] Referring to FIG. 3, the DPPH free radical removal capability of the Dahlia pinnata composition of Example 1 is 72.5% to 74.0%; the DPPH free radical removal capability of the Dahlia pinnata composition of Example 2 is 85.3% to 86.3%; the DPPH free radical removal capability of the Dahlia pinnata composition of Example 3 is 88.07% to 89.07%; the DPPH free radical removal capability of a Dahlia pinnata composition of Example 4 is 88.4 to 89.4%; the DPPH free radical removal capability of the Dahlia pinnata composition of Example 5 is 86.3% to 87.3%; and the DPPH free radical removal capability of the ascorbic acid of Comparative Example is 84.5% to 85.9%. In other words, the Dahlia pinnata composition with a Dahlia pinnata extract content exceeding 250 µg/ml could be confirmed to exhibit an antioxidant efficacy similar to the ascorbic acid.
    [0073] Meanwhile, although not shown, the DPPH free radical removal capability was measured at a content of the range of 5 µg/ml to 20000 µg/ml of the ascorbic acid relative to the solvent. In this measurement, it was confirmed that 81% to 85.9 % of the DPPH free radical removal capability was exhibited in a range of a content of 100 µg/ml to 20000 µg/ml of the ascorbic acid relative to the solvent.
    [0074] Hereinafter, the results of measurement of inhibition of superoxide dismutase (SOD) activity by the Dahlia pinnata compositions of Example 6 to Example 10 will be described with reference to FIG. 4. <Experimental Example 3>
    [0075] In Experimental Example 3, the superoxide dismutase kit (SOD Assay Kit-WST) was used to measure the inhibition of superoxide dismutase activity by the Dahlia pinnata compositions of Example 6 to Example 10. To this end, each of mixtures between the Dahlia pinnata compositions from Examples 6 to 10 and water-soluble tetrazolium salt (WST) solution, superoxide dismutase solution (SOD enzyme solution), buffer solution, dilution water was dispensed into a 96-well plate. The superoxide dismutase (SOD) as an enzyme used in this assay is one of the most important antioxidant enzymes that decomposes superoxide anion (02 -) into hydrogen peroxide (H2O2) and oxygen molecules. The SOD activity inhibition rate was measured based on this mechanism.
    [0076] 200 µl of tetrazolium salt solution and 20 µl of superoxide dismutase solution were added into 20 µl of Dahlia pinnata compositions from Example 6 to Example 10 to form samples. 20 µl of deionized distilled water (ddH2O) was added into 200 µl of tetrazolium salt solution and 20 µl of superoxide dismutase solution to form a first blank. 20 µl of the Dahlia pinnata compositions were added into 200 µl of tetrazolium salt solution and 20 µl of diluting water to form a second blank. 20 µl of deionized distilled water was added into 200 µl of tetrazolium salt solution and 20 µl of diluting water to form a third blank. 240 µl of each of samples and the first to third blanks was dispensed into a 96-well plate and reacted at 37°C for 20 minutes. The absorbances thereof were then measured at 450 nm using a microplate reader (Synergy™ HTX and Synergy™ 2 Multi-Mode Readers, BioTek). The values of the absorbances and the inhibition rate of SOD activity (%) by the Dahlia pinnata compositions of Example 6 to Example 10 were calculated by a following equation: Inhibition rate of SOD activity% = { A blank 1 − A blank 3− A sample − A blank 2 / A blank 1 − A blank 3] × 100 ,
    [0077] FIG. 4 illustrates the inhibition rate of SOD activity by the Dahlia pinnata composition according to an embodiment.
    [0078] As illustrated in FIG. 4, the Dahlia pinnata composition of Example 6 had an average inhibition rate of the SOD activity of 59.1%. In Dahlia pinnata composition of Example 7, the inhibition rate of SOD activity was measured as 52.7% to 69.1%, and the average inhibition rate thereof was measured as 60.9%. In Dahlia pinnata composition of Example 8, the inhibition rate of SOD activity was measured as 71.1% to 76.1% and the average inhibition rate thereof was measured as 73.6%. In Dahlia pinnata composition of Example 9, the inhibition rate of SOD activity was measured as 67.8% to 92.7%, and the average inhibition rate thereof was measured as 80.7%. Further, the Dahlia pinnata composition of Example 10 showed that the inhibition rate of the SOD activity was as 101.2% to 105.6%, and the average inhibition rate thereof was measured as 103.4%. These measurements could also confirm that the Dahlia pinnata compositions effectively inhibited the activity of SOD. The inhibition rate of the activity of SOD by the Dahlia pinnata composition could increase by increasing the content of Dahlia pinnata extract.
    [0079] Referring to the experimental results of Experimental Example 2 and Experimental Example 3, the Dahlia pinnata extract contents in the Dahlia pinnata compositions is preferably in a range between 16 µg/ml to 20000 µg/ml. It was confirmed that the inhibition rates of SOD activity by the Dahlia pinnata compositions smaller than 70% when the content of Dahlia pinnata extract is 16 µg/ml or less, whereas the content of the extract exceeding 20000 µg/ml may reduce the DPPH free radical removal capability.
    [0080] Referring to the graphs of FIG. 3 and FIG. 4, when the Dahlia pinnata extract content in the Dahlia pinnata composition exceeded 10000 µg/ml, the DPPH free radical removal capability decreased. Further, the graphs could confirm that the DPPH free radical removal capability by the Dahlia pinnata composition was 80% or more when the Dahlia pinnata extract content was greater than 250 µg/ml. Further, the inhibition rate of the SOD activity by the Dahlia pinnata composition increased as the extract content increased. When the Dahlia pinnata extract content was smaller than 400 µg/ml, the inhibitory rate of SOD activity was reduced to 100% or less. It may be understood that the Dahlia pinnata composition preferably has a content of Dahlia pinnata extract of 500 µg/ml to 10000 µg/ml.
    [0081] With reference to the above experimental results, the cosmetic composition including the Dahlia pinnata extract preferably includes the Dahlia pinnata extract at a content of 16 µg/ml to 20000 µg/ml relative to the cosmetic composition. More preferably, the content of the Dahlia pinnata extract relative to the cosmetic composition is preferably in a range of 500 µg/ml to 10000 µg/ml.
    [0082] The above experiments have shown that the Dahlia pinnata composition extracted from the Dahlia pinnata petal has an antioxidant effect. These Dahlia pinnata compositions are produced in the form of liquids or powders which are easily added to a variety of foods and cosmetics requiring an antioxidant efficacy.
    [0083] Although the present disclosure has been described with reference to the above-described embodiments, various modifications and changes may be made thereto by those skilled in the art. For example, although the method steps as described are performed in a different order than the described step order or components such as structures, devices, and/or elements as described are combined or coupled in different forms or are substituted or replaced with other components or equivalents than the described components, appropriate results may be achieved.
    权利要求:
    Claims (16)
    [0001] A cosmetic composition having an antioxidant efficacy, the cosmetic composition comprising Dahlia pinnata extract.
    [0002] The composition of claim 1, wherein the cosmetic composition has a content of the Dahlia pinnata extract in a range of from 16 µg/ml to 20000 µg/ml.
    [0003] The composition of claim 2, wherein the cosmetic composition has the content of the Dahlia pinnata extract in a range of from 500 µg/ml to 10000 µg/ml.
    [0004] A method for producing a Dahlia pinnata composition, the method comprising:
    preparing Dahlia pinnata petals;
    adding and stirring ethanol into Dahlia pinnata petals to extract the Dahlia pinnata extract;
    filtering the Dahlia pinnata extract; and
    diluting the filtered Dahlia pinnata extract in a solvent to obtain a Dahlia pinnata composition having an antioxidant efficacy.
    [0005] The method of claim 4, wherein extracting the Dahlia pinnata extract includes adding 5 to 20 ml of the ethanol per 1 g of the Dahlia pinnata petal.
    [0006] The method of claim 4, wherein the Dahlia pinnata composition has a phenolic compound content of 43.1 µg/100 mg to 56.5 µg/100 mg.
    [0007] The method of claim 4, wherein the Dahlia pinnata composition has a content of the Dahlia pinnata extract in a range of from 16 µg/ml to 20000 µg/ml.
    [0008] The method of claim 7, wherein the Dahlia pinnata composition has a content of the Dahlia pinnata extract in a range of from 500 µg/ml to 10000 µg/ml.
    [0009] The method of claim 8, wherein the Dahlia pinnata composition has an ability of an antioxidant component to remove 85% to 89% of DPPH (2,2-diphenyl-1-picrylhydrazyl) free radicals.
    [0010] The method of claim 7, wherein the Dahlia pinnata composition has a content of the Dahlia pinnata extract in a range of from 16 µg/ml to 400 µg/ml.
    [0011] The method of claim 10, wherein the Dahlia pinnata composition has inhibition rate of 71.7% to 105.6% of superoxide dismutase activity.
    [0012] The method of claim 4, wherein filtering the Dahlia pinnata extract includes filtering the Dahlia pinnata extract with a syringe filter.
    [0013] A Dahlia pinnata composition having antioxidant efficacy, the Dahlia pinnata composition being produced by the method of claim 4.
    [0014] A method for producing Dahlia pinnata composition powders, the method comprising:
    lyophilizing the Dahlia pinnata composition produced by the method of claim 4; and
    converting the lyophilized Dahlia pinnata composition into powders form.
    [0015] A Dahlia pinnata cosmetic composition powder having antioxidant efficacy, the Dahlia pinnata composition powder being produced by the method of claim 14.
    [0016] A cosmetic composition having an antioxidant efficacy, the cosmetic composition comprising the Dahlia pinnata composition produced by the method of claim 4.
    类似技术:
    公开号 | 公开日 | 专利标题
    US10653614B2|2020-05-19|Coffee cherry cosmetic composition and methods
    KR101522415B1|2015-05-21|Cosmetic composition including an acanthus extract of ceriporia lacerata and cosmetics using the same
    US6485756B1|2002-11-26|Stable, homogeneous natural product extracts containing polar and apolar fractions
    EP1752156B1|2014-07-30|Active oxygen eliminator and moisturizer containing wild watermelon extract
    US20130028996A1|2013-01-31|Bioactive botanical cosmetic compositions and processes for their production
    JP4730642B2|2011-07-20|Active oxygen scavenger and composition thereof
    EP2654766A1|2013-10-30|Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same
    BRPI0506751B1|2019-12-31|method to isolate a bioactive fraction derived from cellular juice from a camellia sinensis plant
    US8916212B2|2014-12-23|Skin whitening composition containing chia seed extract
    JPH0717847A|1995-01-20|Skin external preparation
    EP1217984A1|2002-07-03|Cosmetic preparation of active substances with a synergistically increased radical protection factor
    KR20150019276A|2015-02-25|Cosmetic composition including an extract of the tissue-cultured dendrobium, and preparatioin method of the extract
    KR100556524B1|2006-03-06|Camellia japonica extract having anti-inflammatory and anti-oxidative activities, and cosmetic composition comprising the same
    JP2004067590A|2004-03-04|Female sex hormone production promoter and skin preparation for external use containing the same
    JP3053368B2|2000-06-19|Cosmetic and method for producing the same
    EP2276457B1|2017-11-29|Use of myrtle extract as depigmenting agent
    KR101873028B1|2018-07-02|Cosmetic composition containing complex extract of herbs
    EP1536764B1|2008-04-09|Cosmetic composition for fighting against skin ageing
    JP2008247854A|2008-10-16|Antioxidant, dna damage suppressant, and external skin preparation
    JP2008156325A|2008-07-10|External preparation for skin and skin-lightening agent
    JP3407935B2|2003-05-19|External preparation for skin
    KR101402550B1|2014-06-02|Antioxidizing Functional Cosmetic Compositions for Containing Extracted/Fermented Dendropanax morbifera Products and Functional Cosmetics Produced Thereby
    JPH0761915A|1995-03-07|External agent for skin
    JP2007261987A|2007-10-11|Tyrosinase inhibitor, process for its preparation and its use
    KR20160021676A|2016-02-26|Cosmetic Compositions with Whitening and Anti-oxidative Effect Comprising of Phragmitis Rhizoma, Salicomia herbacea L. and Prunus mume
    同族专利:
    公开号 | 公开日
    JP2021502396A|2021-01-28|
    US20200337986A1|2020-10-29|
    WO2019146889A1|2019-08-01|
    US10842734B2|2020-11-24|
    EP3692979A4|2020-12-23|
    KR101920650B1|2019-01-30|
    CN111315355A|2020-06-19|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    法律状态:
    2019-08-03| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
    2020-07-10| PUAI| Public reference made under article 153(3) epc to a published international application that has entered the european phase|Free format text: ORIGINAL CODE: 0009012 |
    2020-07-10| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
    2020-08-12| 17P| Request for examination filed|Effective date: 20200505 |
    2020-08-12| AX| Request for extension of the european patent|Extension state: BA ME |
    2020-08-12| AK| Designated contracting states|Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
    2020-11-25| RIN1| Information on inventor provided before grant (corrected)|Inventor name: JO, HAN NA Inventor name: KIM, SUNG TAE Inventor name: RYU, KEONG A Inventor name: PARK, RAE HYUN Inventor name: JANG, DONG JIN |
    2020-12-23| A4| Supplementary search report drawn up and despatched|Effective date: 20201119 |
    2020-12-23| RIC1| Information provided on ipc code assigned before grant|Ipc: A61K8/978920170101AFI20201113BHEP Ipc: A61Q 19/00 20060101ALI20201113BHEP Ipc: A61Q 19/08 20060101ALI20201113BHEP Ipc: A61K8/02 20060101ALI20201113BHEP |
    2021-02-15| REG| Reference to a national code|Ref country code: DE Ref legal event code: R079 Ref document number: 602018021006 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A61K0008978900 Ipc: A61K0008400000 |
    2021-03-02| GRAP| Despatch of communication of intention to grant a patent|Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
    2021-03-02| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: GRANT OF PATENT IS INTENDED |
    2021-03-24| RIC1| Information provided on ipc code assigned before grant|Ipc: A61Q 19/08 20060101ALI20210215BHEP Ipc: A61K8/978920170101ALI20210215BHEP Ipc: A61K8/40 20060101AFI20210215BHEP |
    2021-03-31| DAX| Request for extension of the european patent (deleted)|
    2021-03-31| DAV| Request for validation of the european patent (deleted)|
    2021-03-31| INTG| Intention to grant announced|Effective date: 20210303 |
    2021-06-18| GRAS| Grant fee paid|Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
    2021-06-25| STAA| Information on the status of an ep patent application or granted ep patent|Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
    2021-06-25| GRAA| (expected) grant|Free format text: ORIGINAL CODE: 0009210 |
    2021-07-28| AK| Designated contracting states|Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
    2021-07-28| REG| Reference to a national code|Ref country code: GB Ref legal event code: FG4D |
    2021-07-30| REG| Reference to a national code|Ref country code: CH Ref legal event code: EP |
    2021-08-12| REG| Reference to a national code|Ref country code: DE Ref legal event code: R096 Ref document number: 602018021006 Country of ref document: DE |
    2021-08-15| REG| Reference to a national code|Ref country code: AT Ref legal event code: REF Ref document number: 1414051 Country of ref document: AT Kind code of ref document: T Effective date: 20210815 |
    2021-08-18| REG| Reference to a national code|Ref country code: IE Ref legal event code: FG4D |
    2021-10-13| REG| Reference to a national code|Ref country code: NL Ref legal event code: FP |
    2021-11-10| REG| Reference to a national code|Ref country code: LT Ref legal event code: MG9D |
    2021-12-15| REG| Reference to a national code|Ref country code: AT Ref legal event code: MK05 Ref document number: 1414051 Country of ref document: AT Kind code of ref document: T Effective date: 20210728 |
    2022-01-13| REG| Reference to a national code|Ref country code: ES Ref legal event code: FG2A Ref document number: 2889777 Country of ref document: ES Kind code of ref document: T3 Effective date: 20220113 |
    2022-01-31| PG25| Lapsed in a contracting state [announced via postgrant information from national office to epo]|Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210728 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210728 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210728 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210728 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211028 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211129 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210728 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20211028 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210728 |
    2022-01-31| PGFP| Annual fee paid to national office [announced via postgrant information from national office to epo]|Ref country code: FR Payment date: 20211119 Year of fee payment: 4 Ref country code: DE Payment date: 20211129 Year of fee payment: 4 Ref country code: ES Payment date: 20211216 Year of fee payment: 4 Ref country code: NL Payment date: 20211119 Year of fee payment: 4 |
    2022-02-28| PG25| Lapsed in a contracting state [announced via postgrant information from national office to epo]|Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210728 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20210728 |
    优先权:
    申请号 | 申请日 | 专利标题
    [返回顶部]